MedPath

Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
Registration Number
NCT02958514
Lead Sponsor
Peking University Third Hospital
Brief Summary

This study aims to evaluate the efficacy of intense pulsed light in treating dry eye caused by meibomian gland dysfunction and make a comparison between the traditional treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • patients with dry eye syndrome and diagnosed as MGD
Read More
Exclusion Criteria
  • an infection or inflammatory disease;
  • ocular surgical history with in the last 3 months
  • SGOGREN SYNDROME
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
traditional treatment groupTobramycin and Dexamethasone Ophthalmic OintmentSubjects in this group are treated by tobramycin and dexamethasone ophthalmic ointment qn and artificial tears qid.
IPL treatment groupintense pulsed lightSubjects in this group are treated with 3 cycles of intense pulsed light of 4 weeks interval and artificial tears qid.
Primary Outcome Measures
NameTimeMethod
Ocular Surface Disease Index (OSDI)through study completion,an average of 6 months

normal value:\<13 abnormal value:≥ 13

Secondary Outcome Measures
NameTimeMethod
Corneal Fluorescein Stain(CFS)through study completion,an average of 6 months
Eyelid ester discharge ability scorethrough study completion,an average of 6 months
Eyelid ester trait ratingsthrough study completion,an average of 6 months
breakup time of tear film (BUT)through study completion,an average of 6 months

normal value:\>10s abnormal value:≤ 10s

The concentrations of inflammatory cytokines such as IL-1、IL-6 and IL-8through study completion,an average of 6 months
© Copyright 2025. All Rights Reserved by MedPath